Belgium-Based Cardio3 BioSciences Opens Operations Hub In Rochester, Minnesota
03/23/2015
The facility will also serve as a base for the Company’s research and clinical collaboration with Mayo Clinic, also based in Rochester. In addition, the new center will support the Company’s current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure, and its recently acquired CAR T-cell therapies’ portfolio.
C-Cure is an autologous cellular therapy for the treatment of congestive heart failure that is based on the Company’s proprietary Cardiopoiesis platform, initially developed using fundamental research and proprietary technology from the Mayo Clinic.
Christian Homsy, CEO of Cardio3 BioSciences said, “ We are very thankful to Rochester, RAEDI and DEED for the efforts that they made in facilitating the public assistance and location for our facility. Our plans for this facility will first be to manage the manufacturing-related activities associated with the U.S. portion of CHART-2, our second global Phase III clinical trial for C-Cure.”
Cardio3 BioSciences will receive non-dilutive funding from the Minnesota Department of Employment and Economic Development and the Minnesota Job Creation Fund once it completes its investment and hiring goals.
RAEDI President Gary Smith said, “Securing Cardio3 BioSciences’ newest United States location in Rochester is the result of an expansive effort led by Rochester Area Economic Development, the City of Rochester, Mayo Clinic, and the Minnesota Department of Employment and Economic Development, and we appreciate all who championed the endeavour. Cardio3 BioSciences will anchor our area’s emerging Regenerative Medicine Cluster with its focus on developing leading cellular therapies, and we encourage members of the community to welcome the Company.”
Project Announcements
JDSAT Expands Fairfax County, Virginia, Operations
04/25/2024
Trussworks Mid-America Plans Jackson, Missouri, Manufacturing Operations
04/25/2024
Epic Flight Academy Establishes Hebron, Kentucky, Operations
04/25/2024
EPC-Columbia Expands Lebanon, Kentucky, Plastic Injection Molding Operations
04/25/2024
Daisy Brand Plans Boone, Iowa, Production Operations
04/22/2024
Canfor Expands Fulton, Alabama, Production Operations
04/22/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024